Skip to main content

Unleashing Europe’s Biopharmaceutical Innovation Potential: What can be done to accelerate AIDS vaccine research and development?

December 01, 2008
Europe’s significant scientific capacity could prove pivotal in the quest for an AIDS vaccine. This policy brief discusses key challenges, such as a translational research gap, that must be addressed to best harness Europe’s expertise.
Page

If you have Adobe PDF Viewer, you can browse the publication below.
Otherwise click here to download the PDF.